Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles

被引:36
作者
Mitsios, John V.
Vini, Maria P.
Stengel, Dominique
Ninio, Ewa
Tselepis, Alexandros D. [1 ]
机构
[1] Univ Ioannina, Dept Chem, Biochem Lab, Ioannina 45110, Greece
[2] Univ Paris 06, INSERM, U525, Paris, France
[3] Fac Med Pierre & Marie Curie, Paris, France
关键词
atherosclerosis; inflammation; PAF; PAF-acetyhydrolase; PMPs;
D O I
10.1161/01.ATV.0000228821.79588.ef
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Platelet-activating factor acetylhydrolase (PAF-AH) expresses a Ca2+-independent phospholipase A, activity and hydrolyzes platelet-activating factor as well as oxidized phospholipids. Two major types of PAF-AH have been described: the plasma type, which is associated with lipoproteins, and the intracellular type II PAF-AH. Methods and Results-We investigated the type(s) of PAF-AH expressed in human platelets as well as the mechanism and the enzyme type secreted from platelets during activation. The majority of the enzyme activity (75.1 +/- 14.3% of total) is found in the cytosol, whereas 24.9 +/- 7.3% is associated with the membranes. Immunofluorescence microscopy studies and Western blotting analysis showed that platelets contain the plasma type as well as the intracellular type II PAF-AH. Furthermore, platelets contain high levels of the mRNA of plasma PAF-AH, whereas only a small quantity of the type II PAF-AH mRNA was detected. On activation, platelets secrete the plasma type of PAF-AH mainly associated with platelet-derived microparticles (PMPs). The enzyme activity was also detected on circulating PMPs in plasma from normolipidemic healthy subjects. Conclusion-This is the first indication that in addition to lipoproteins, PAF-AH in human plasma is carried by PMPs, suggesting that the PMP-associated PAF-AH may play a role in the dissemination of biological activities mediated by these particles.
引用
收藏
页码:1907 / 1913
页数:7
相关论文
共 43 条
[1]   Platelet-activating factor acetylhydrolase (PAF-AH) [J].
Arai, H ;
Koizumi, H ;
Aoki, J ;
Inoue, K .
JOURNAL OF BIOCHEMISTRY, 2002, 131 (05) :635-640
[2]   Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma [J].
Asano, K ;
Okamoto, S ;
Fukunaga, K ;
Shiomi, T ;
Mori, T ;
Iwata, M ;
Ikeda, Y ;
Yamaguchi, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) :511-514
[3]   Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells [J].
Baj-Krzyworzeka, M ;
Majka, M ;
Pratico, D ;
Ratajczak, J ;
Vilaire, G ;
Kijowski, J ;
Reca, R ;
Janowska-Wieczorek, A ;
Ratajczak, MZ .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (05) :450-459
[4]   Mechanisms of cellular activation by platelet microparticles [J].
Barry, OP ;
FitzGerald, GA .
THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) :794-800
[5]   Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles [J].
Barry, OP ;
Pratico, D ;
Lawson, JA ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) :2118-2127
[6]   High levels of circulating endothelial microparticles in patients with acute coronary syndromes [J].
Bernal-Mizrachi, L ;
Jy, W ;
Jimenez, JJ ;
Pastor, J ;
Mauro, LM ;
Horstman, LL ;
de Marchena, E ;
Ahn, YS .
AMERICAN HEART JOURNAL, 2003, 145 (06) :962-970
[7]   Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up [J].
Brilakis, ES ;
McConnell, JP ;
Lennon, RJ ;
Elesber, AA ;
Meyer, JG ;
Berger, PB .
EUROPEAN HEART JOURNAL, 2005, 26 (02) :137-144
[8]   Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation [J].
del Conde, I ;
Shrimpton, CN ;
Thiagarajan, P ;
López, JA .
BLOOD, 2005, 106 (05) :1604-1611
[9]   Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase [J].
Dentan, C ;
Tselepis, AD ;
Chapman, MJ ;
Ninio, E .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1299 (03) :353-357
[10]   Cellular microparticles: what are they bad or good for? [J].
Freyssinet, JM .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1655-1662